Cannabis Investing Network

In this episode we are joined by Jarrett Annenberg of Newlake Capital Partners. NLCP is a new OTC listed public cannabis REIT who owns dispensaries and cultivation facilities across the US. Their largest tenants include Curaleaf, Cresco, Trulieve, Columbia Care and other single and multi-state operators. We touch on a wide variety of topics including: - Why a delayed SAFE banking will help Newlake...

In this episode we are joined by Alan "The Maven" Brochstein. Alan is an extremely experienced cannabis analyst who has been covering the sector since 2014. He is co-founder of New Cannabis Ventures and founder of 420investor.  In this wide ranging conversation we discuss many different topics including: - State of the market: how AB sees the cannabis stock action compared to previous years -...

In this mega-episode our good friend Nick Gastevich joins us for the Q3 2021 quarterly review of Cresco, Curaleaf, Trulieve, Green Thumb, and Verano (in that order). We do a deep dive into profitability, cash flow, brands, valuation and how we see the strengths and weaknesses of each company. We discuss how well positioned each of these companies is for the current phase of our industry and for th...

What a difference 2 weeks makes! In this episode we discuss a few key themes around the biggest issues we are seeing in today's market 1) Narratives vs Reality - how the divergence creates opportunity for investors 2) Nancy Mace Legalization bill - what this really means and the effect its having on the market 3) $MSOS huge cash inflows and how we expect this to impact the cannabis stock market sh...

In this episode (which was recorded on Fri Nov 5th) we discuss the rapid sentiment shift from "Depression" to "Euphoria" and why it is an excellent real-time example of the inefficiency of the cannabis investing market. We often discuss how our market behaves irrationally but in this episode we delve into the reasons why it is that way, examples of irrational behaviour and strategies to take advan...

This week we are joined by fan-favourite Nick Gastevich (aka CannaVestments). Nick is an OG cannabis investor whose family office invested in GTI's first round in 2014 (and again in subsequent years).  In this episode we discuss: - General negativity in the cannabis sector - Schumer, SAFE, NDAA and federal politics - Q3 financial softness in key markets of PA/FL - Other headwinds which can ma...

In this (slightly late) episode we debrief a phenomenal MJ Biz conference including our takeaways, the negatives, the positives and our strategies for the coming quarters. JP October SAFE/NDAA Update - https://www.reddit.com/r/weedstocks/comments/qc4h27/understanding_washington_october_updates/  

In this episode we talk about how we can "sharpen our swords" and focus on improving our investing abilities. We talk about mistakes we've made (and re-made), what we've learned and some of the easiest ways to work on your cannabis IQ, investing knowledge and research capabilities in order to (hopefully) reach better outcomes.

In this episode we’re joined by Sayshu Medicherla ( @Sayshu_MM ), the Founder/CIO of MM Fund.  He has extensive experience investing professionally across a variety of asset classes and strategies including public equities, venture capital, private equity, and credit. We cover two major topics today: First, we discuss different ways to approach investing in cannabis and why it’s important to...

In this episode we are joined by George Archos who is CEO, Chairman and Co-Founder of Verano Holdings.  In this interview we discuss: - Background: How George got started in the restaurant industry - What makes a restaurant successful and why its a good training ground for the cannabis industry - Verano Orgins: How the company got started by winning an IL cultivation license - Expansion Years...

In this episode we discuss the importance of admitting "I don't know" when it comes to investing in this sector.  We discuss how "I don't know" can be helpful for: - Taking a more cautious approach to building your portfolio - Federal change, the SAFE act and NDAA news - Selecting which markets are attractive - Evaluating headlines and social media - Managing your cash position  - Buying...

In this episode we are joined by special guest, Jason, who worked in Washington D.C. for a House Appropriations Chairman and focused on financial services and trade issues. During his career in D.C., he was an integral member of two lobbying groups that advocated for safe and fair trade issues and economic investment in American cities.  He is still heavily involved in the political worl...

In this episode, we are joined with the guru of the golden coast Hirsh Jain! Hirsh is the founder of Ananda Strategy, a consultancy that works with many of California's leading cannabis brands and retailers and has helped its clients operationalize some of the most successful cannabis facilities in the state. In this action packed episode we try to further understand the California cannabis landsc...

Joining us today is Abner Kurtin who is CEO, Chairman and Co-Founder of Ascend Wellness Holdings (AWH). Abner’s background is as an investor – starting at the highly regarded Baupost and moving on to starting his own hedge fund. He raised $50M to invest in the cannabis space before switching gears and Co-Founding Ascend in 2018. In only 3 years Ascend has become a top player in IL with an eye to r...

In this mega-episode our good friend Nick Gastevich joins us for the Q2 2021 quarterly review of Cresco, Curaleaf, Green Thumb, Trulieve and Verano (in that order). We do a deep dive into profitability, cash flow, brands, valuation and how we see the strengths and weaknesses of each company. As the cannabis market trades poorly we discuss how valuations between these top tier companies have diverg...

In this end of August market update we discuss negative market chatter we are hearing. We try to answer - "How long can this go on? And how bad can it get?"  The simple answer is that we don't know - but we think through some of the bear cases for our sector. We also discuss how to win as an investor in a down market. The theme of the episode is that investors are spoiled for choice right now...

In this episode we discuss why we believe the market has swung back to "Golden Opportunity" territory and the dynamics behind the shift. In particular we dig into Trulieve and Verano and explain why we think these two names are have fallen to very attractive multiples based on 2022 EBITDA.

In this episode we ask - what is wrong with cannabis stocks? Why is it despite all the good news, earnings and fundamental progress occurring the cannabis sector continues to bleed red? Should investors be worried that something is wrong or excited about the opportunity this presents? In this episode we discuss: - Earnings season and how stocks seem numb - The set up: how we got here - Human psych...

Part 2/2 - In this episode we are joined by fan favourite Nick Gastevich aka CannaVestments to do a deep dive into 7 of our favourite up and coming mid and small cap MSOs. Part 2 has smaller cap companies with potentially more upside but also additional execution risk. In part 2 of this analysis we go over: Our Picks for #4-7: 4) Pharmacann (private) 5) Vireo / Goodness Growth 6) Jushi 7) Cansorti...

In this episode we are joined by fan favourite Nick Gastevich aka CannaVestments to do a deep dive into 7 of our favourite up and coming mid and small cap MSOs. We also go over market sentiment, reactions to Schumers bill and why it is worthwhile to look at mid cap MSOs. In part 1 of this analysis we go over: Our Top 3 Picks: 1) AYR Wellness 2) Ascend Wellness 3) Columbia Care - Ranking: Why we fe...

In this episode we are once again joined with a special guest, Chris Murray.  Chris and Abi discuss a wide array of topics that affect the social stigma in cannabis along with potential factors which are affecting other sectors and could spill over to cannabis. First we briefly touch on Sha'carri Richardson's recent disqualification in the upcoming Tokyo Olympics after testing positive for TH...

In this episode we discuss last week's Jefferies ~300 page research report on the US Cannabis industry. The investment bank covers many MSOs, US markets and projects out sales to 2030.  We discuss why we think the headline is true but potentially misleading, try to measure how much upside we see in the next 2-3 years, discuss forward margins and EBITDA multiples and discuss our strategy for e...

Nostalgia time! In this episode we dive into our experiences over the last 2+ years and discuss how the market has evolved since we started this podcast. While many things have changed, the parallels between market boom and bust, the nature of retail investors and the emotional turmoil of the highs and lows are eerily similar to 2019. We discuss how our past experiences (and mistakes) have hopeful...

In this mega-episode our good friend Nick Gastevich joins us for the Q1 quarterly review of Curaleaf, Trulieve, Cresco Labs, Green Thumb and Verano. We do a deep dive into profitability, core footprints, valuation and how we see the future for each company.  As the broader peer set trades between 10-14X '22 EBITDA we feel the time is right for acquiring these big 5 MSOs. We discuss the theme...

We are joined by a special guest, Andrew Semple from Echelon Wealth Partners.  Andrew was recently highlighted as the top performing analyst on Bay St by the Globe and Mail.  He's a fundamental investor at heart and finds value in growth stocks. In this episode we gain insights on federal reform, select limited license states and US MSO's.  As well we gain insights on how Semple beg...